Oncology Institute (NASDAQ:TOI) Stock Price Up 5.4% – What’s Next?

The Oncology Institute, Inc. (NASDAQ:TOI)’s stock price rose 5.4% on Wednesday . The stock traded as high as $0.32 and last traded at $0.30. Approximately 622,742 shares were traded during mid-day trading, an increase of 342% from the average daily volume of 140,991 shares. The stock had previously closed at $0.28.

Oncology Institute Stock Up 5.4 %

The company has a debt-to-equity ratio of 3.08, a current ratio of 3.31 and a quick ratio of 2.99. The firm’s 50 day moving average is $0.32 and its two-hundred day moving average is $0.49. The firm has a market capitalization of $22.27 million, a P/E ratio of -0.37 and a beta of 0.60.

Oncology Institute (NASDAQ:TOI) last released its earnings results on Tuesday, August 13th. The company reported ($0.17) earnings per share for the quarter, missing the consensus estimate of ($0.10) by ($0.07). The firm had revenue of $98.58 million during the quarter, compared to the consensus estimate of $103.31 million. Oncology Institute had a negative net margin of 18.86% and a negative return on equity of 136.63%. During the same period in the prior year, the business posted ($0.19) earnings per share.

Hedge Funds Weigh In On Oncology Institute

Several large investors have recently modified their holdings of TOI. Renaissance Technologies LLC grew its stake in shares of Oncology Institute by 142.3% in the second quarter. Renaissance Technologies LLC now owns 339,400 shares of the company’s stock valued at $156,000 after acquiring an additional 199,300 shares in the last quarter. Tiff Advisory Services LLC lifted its holdings in shares of Oncology Institute by 235.1% in the second quarter. Tiff Advisory Services LLC now owns 1,418,685 shares of the company’s stock worth $653,000 after acquiring an additional 995,280 shares during the last quarter. FourWorld Capital Management LLC bought a new position in shares of Oncology Institute in the first quarter worth about $396,000. Kent Lake Capital LLC lifted its holdings in shares of Oncology Institute by 9.4% in the first quarter. Kent Lake Capital LLC now owns 1,186,713 shares of the company’s stock worth $1,875,000 after acquiring an additional 101,542 shares during the last quarter. Finally, Nwam LLC bought a new position in shares of Oncology Institute in the first quarter worth about $44,000. 36.86% of the stock is owned by institutional investors.

About Oncology Institute

The Oncology Institute, Inc, an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services.